DIMENSIONAL FUND ADVISORS LP

Position in CMPX — Compass Therapeutics, Inc.

CIK 354204 AUSTIN, TX

Position in CMPX

as of Mar 31, 2026 · filed May 7, 2026 Compact

Position Value

$2,326,456

+$492,088 QoQ

Shares Held

439,784

+28.7% QoQ

Ownership

0.244%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 63.784266821894384.ToString("F0")% Shared 16.411465628581304.ToString("F0")% None 19.80426754952431.ToString("F0")%

Healthcare · as of Mar 31, 2026

DIMENSIONAL FUND ADVISORS LP holds $5,003,215,874 across 223 Biotechnology names. CMPX ranks #119 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	989,342	$441,780,774
2	REGN	Regeneron Pharmaceuticals, Inc.	513,060	$396,410,676
3	JAZZ	Jazz Pharmaceuticals plc	1,895,215	$358,290,394
4	BMRN	Biomarin Pharmaceutical Inc	3,802,930	$214,827,514
5	ROIV	Roivant Sciences Ltd.	7,475,866	$207,081,486
6	INCY	Incyte Corp	1,975,544	$185,938,199
7	EXEL	Exelixis, Inc.	4,299,597	$184,409,714
8	HALO	Halozyme Therapeutics, Inc.	2,079,827	$134,419,216

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,326,456	439,784	+28.7%	Shares	Sole	2026-05-07
2025-12-31	$1,834,368	341,596	+94.6%	Shares	Sole	2026-02-12
2025-09-30	$614,445	175,556	+1.9%	Shares	Sole	2025-11-12
2025-06-30	$447,787	172,227	+24.1%	Shares	Sole	2025-08-12
2025-03-31	$263,722	138,802	+1148.6%	Shares	Sole	2025-05-13
2024-12-31	$16,119	11,117	0.0%	Shares	Sole	2025-02-13
2024-09-30	$20,455	11,117	0.0%	Shares	Sole	2024-11-07
2024-06-30	$11,117	11,117	0.0%	Shares	Sole	2024-08-09
2024-03-31	$22,011	11,117	0.0%	Shares	Sole	2024-05-10
2023-12-31	$17,342	11,117	-0.4%	Shares	Sole	2024-02-07
2023-09-30	$21,986	11,161	-63.3%	Shares	Sole	2023-11-09
2023-06-30	$96,830	30,450	—	Shares	Sole	2023-08-09
No filing history on record for this holder in this stock.